Medicine. Stroke--tPA and the clinic.

Journal Article (Journal Article)

Clinical trial results are not always rapidly incorporated into routine medical practice. This Policy Forum describes a variety of barriers that have impeded the more widespread use of thrombolytic therapy (tPA, tissue plasminogen activator) for selected patients with acute ischemic stroke. These barriers are not insurmountable but will require a concerted effort to overcome.

Full Text

Duke Authors

Cited Authors

  • Marler, JR; Goldstein, LB

Published Date

  • September 19, 2003

Published In

Volume / Issue

  • 301 / 5640

Start / End Page

  • 1677 -

PubMed ID

  • 14500967

Electronic International Standard Serial Number (EISSN)

  • 1095-9203

Digital Object Identifier (DOI)

  • 10.1126/science.1090270


  • eng

Conference Location

  • United States